Clinical trial
Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended…
NCT00165854 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00165854 |
|---|---|
| Title | Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer (CRC) |
| Intervention type | Drug |
| Interventions | E7070 |
| Enrollment | 46 |
| Start date | Mar 1, 2003 |
| First posted | Sep 14, 2005 |
| Last update posted | Jun 27, 2014 |
| Countries | France, Germany, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: